Tekla Life Sciences Investors
Financial ServicesNYSE:HQL · New York Stock Exchange
+$0.09 today
Vol 0.10M · Avg 0.10M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $85.6M +282.9% | $22.4M +21468.6% | -$104.6K -262.1% | $64.5K -47.6% | $123.1K | $476.4M | $465.2M | -$1.6B |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $1.2B | $631.8M | $1.5B |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$1.5B | $304.2M | $472.2M |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $354.6M | -$1.6B | $1.2B |
| Change in Working Capital | -$203.4K | $0 | $0 | $0 | $0 | -$1.6B | $1.5B | $1.0B |
| Accounts Receivables | $59.2K | $0 | $0 | $0 | $0 | $1.3B | $626.2M | $1.3B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.2B | $1.1B | $1.2B |
| Accounts Payables | $0 | $0 | $0 | $0 | $0 | -$1.5B | $433.0M | $1.0B |
| Other Working Capital | -$262.6K | $0 | $0 | $0 | $0 | $1.3B | $601.0M | -$1.6B |
| Other Non-Cash Items | -$87.7M -292.4% | -$22.4M -21468.6% | $104.6K +262.1% | -$64.5K +47.6% | -$123.1K | -$1.5B | $300.0M | $468.0M |
| Operating Cash Flow | -$2.3M | $0 | $0 | $0 | $0 | $8.9B | $10.5B | $12.2B |
| Capital Expenditures | -$5 | $0 | $0 | $0 | $0 | $1.4B | $697.6M | $1.4B |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.3B | $1.4B |
| Purchases of Investments | -$314.1M | $0 | $0 | $0 | $0 | $1.4B | $1.3B | $1.1B |
| Sales of Investments | $339.3M | $0 | $0 | $0 | $0 | $318.2M | -$1.5B | $1.0B |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $370.0M | $1.2B | $974.8M |
| Investing Cash Flow | $25.2M | $0 | $0 | $0 | $0 | $6.4B | $5.1B | $6.8B |
| Debt Repayment | $0 | $0 | $0 | $0 | $0 | $759.2M | $1.1B | $1.2B |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $946.8M | $812.4M | $980.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | -$1.6B | $1.5B | $1.0B |
| Dividends Paid | -$31.6M | $0 | $0 | $0 | $0 | $613.6M | $692.0M | $1.1B |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $1.3B | $1.1B | $529.6M |
| Financing Cash Flow | -$31.6M | $0 | $0 | $0 | $0 | $13.9B | -$15.5B | $3.2B |
| Effect of Forex Changes | $8.8M | $0 | $0 | $0 | $0 | $1.1B | $990.2M | $855.8M |
| Net Change in Cash | $75.5K +235953.1% | $32 +105.9% | -$545 | $0 | $0 | $4.9B | $6.5B | $8.2B |
| Free Cash Flow | -$2.3M | $0 | $0 | $0 | $0 | -$16.8B | $11.1B | $5.4B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Gladstone Investment Corporation
NASDAQ:GAIN
$613.21M
Eagle Point Credit Company Inc.
NYSE:ECC
$505.04M
Gladstone Capital Corporation
NASDAQ:GLAD
$438.08M
Crescent Capital BDC, Inc.
NASDAQ:CCAP
$414.89M
Source Capital, Inc.
NYSE:SOR
$372.45M
Barings Corporate Investors
NYSE:MCI
$365.89M
CION Investment Corporation
NYSE:CION
$347.53M
BlackRock TCP Capital Corp.
NASDAQ:TCPC
$317.99M
PennantPark Investment Corporation
NYSE:PNNT
$251.39M
GigCapital7 Corp.
GIG
$172.00M
SEC Filings
Recent regulatory filings
No filings found.
Does HQL generate free cash flow?
Tekla Life Sciences Investors (HQL) generated -$2,320,290.00 of free cash flow in fiscal 2025.
How much operating cash flow does HQL produce?
Operating cash flow was -$2,320,285.00, before capital expenditures of $5.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.